NUCLEXIS
Dead / Abandoned — Abandoned — no statement of use filed (as of 10 Feb 2020)
What this means for you
This application is over — abandoned 10 Feb 2020. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87719775
- Mark type
- Stylized text
- Filed
- 13 Dec 2017
- Published for opposition
- 13 Nov 2018
- Abandoned
- 10 Feb 2020
- Attorney of record
- Nicole Kinsley, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation in humans and animals
Owner
- Karyopharm Therapeutics Inc., Newton, MA, US
- Karyopharm Therapeutics Inc., Newton, MA, US
Prosecution history
- 10 Feb 2020 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 10 Feb 2020 — ABANDONMENT - NO USE STATEMENT FILED
- 02 May 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Apr 2019 — SOU EXTENSION 1 GRANTED
- 30 Apr 2019 — SOU EXTENSION 1 FILED
- 30 Apr 2019 — SOU TEAS EXTENSION RECEIVED
- 08 Jan 2019 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 13 Nov 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 13 Nov 2018 — PUBLISHED FOR OPPOSITION
- 24 Oct 2018 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 25 Sept 2018 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 Sept 2018 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 24 Sept 2018 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 24 Sept 2018 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 23 Mar 2018 — NOTIFICATION OF NON-FINAL ACTION E-MAILED